ReviewCancers2023
Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers.
Jiaxuan Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this papercites it
ReviewCancers2023
Jiaxuan Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.